A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
Status:
Completed
Trial end date:
2024-03-12
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to look if the study drug, tirzepatide, gets into the
breast milk and if yes, how long it takes the body to get rid of it. The study drug will be
given as a single injection under the skin in healthy lactating females. For each
participant, the total duration of the study will be approximately 8 weeks, including
screening.